Full year 2025 total revenues increased by 27% to US$376.1 million, driven by continued growth of RUCONEST® and rising demand for Joenja® ...

Full year 2025 total revenues increased by 27% to US$376.1 million, driven by continued growth of RUCONEST and rising demand for Joenja (leniolisib) Fourth quarter 2025 total revenues increased by 15% ...

My journey has been a long one. I am a paediatric immunologist and principal investigator of a PID research laboratory, and ...